ARG20055
anti-Bid antibody
anti-Bid antibody for Immunohistochemistry,Immunoprecipitation,Western blot and Human
Cancer antibody; Cell Biology and Cellular Response antibody; Cell Death antibody; Metabolism antibody; Apoptosis Marker antibody; Pro-apoptotic Bcl2 protein antibody
1
Overview
Product Description | Rabbit Polyclonal antibody recognizes Bid |
---|---|
Tested Reactivity | Hu |
Tested Application | IHC, IP, WB |
Specificity | The antibody detects 22 kDa Human Bid. |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | IgG |
Target Name | Bid |
Antigen Species | Human |
Immunogen | Synthetic peptide surrounding aa. 37 of Human Bid. |
Conjugation | Un-conjugated |
Alternate Names | p22 BID; BID; p15 BID; p11 BID; BH3-interacting domain death agonist; p13 BID; FP497 |
Application Instructions
Application Suggestion |
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Application Note | * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
Properties
Form | Liquid |
---|---|
Purification | Affinity Purified Antibody |
Buffer | PBS (pH 7.2), 30% Glycerol, 0.5% BSA and 0.01% Thimerosal |
Preservative | 0.01% Thimerosal |
Stabilizer | 30% Glycerol, 0.5% BSA |
Concentration | 0.5 mg/ml |
Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
Database Links |
Swiss-port # P55957 Human BH3-interacting domain death agonist |
---|---|
Background | Bid, a BH3 domain-containing proapoptotic Bcl-2 family member, is localized in the cytosolic fraction of cells as an inactive precursor. Its active form is generated upon proteolytic cleavage by caspase-8 in the Fas signaling pathway. Cleaved Bid translocates to mitochondria and releases its potent proapoptotic activity, which in turn induces cytochrome c release and mitochondrial damage. The cytochrome c releasing activity of Bid was antagonized by Bcl-2. Mutation in the SH3 domain can diminish the cytochrome c releasing activity. In the animal model studies, Bid-deficient mice are found resistant to the lethal effects of death factor signals relayed through Fas. |
Highlight | Related Antibody Duos and Panels: ARG30269 Apoptosis Marker Antibody Duo (Bcl2, Bid) Related products: Bid antibodies; Bid Duos / Panels; Anti-Rabbit IgG secondary antibodies; |
Research Area | Cancer antibody; Cell Biology and Cellular Response antibody; Cell Death antibody; Metabolism antibody; Apoptosis Marker antibody; Pro-apoptotic Bcl2 protein antibody |
Calculated MW | 22 kDa |
PTM | TNF-alpha induces a caspase-mediated cleavage of p22 BID into a major p15 and minor p13 and p11 products. p15 BID is ubiquitinated by ITCH; ubiquitination results in proteasome-dependent degradation. |